Evidence map›Paper›PMID 37724516›Full record

ArticleRenal failure2023

Could long-term dialysis vintage and abnormal calcium, phosphorus and iPTH control accelerate aging among the maintenance hemodialysis population?

Yingxin Zhang, Huan Yang, Zhengling Yang, Xiuyong Li, Zhi Liu, Youwei Bai, Guangrong Qian, Han Wu, Ji Li, Yuwen Guo and 21 more

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 14 institutions in 1 country.

Yingxin ZhangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Huan YangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zhengling YangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Xiuyong LiBlood Purification Center, NO.2 People's Hospital of Fuyang City, Fuyang, China.
Zhi LiuDepartment of Nephrology, The First Affiliated Hospital of Anhui University of Science & Technology, Hefei, Anhui, China.
Youwei BaiDepartment of Nephrology, The Second People's Hospital of Lu'an City, Lu'an, China.
Guangrong QianDepartment of Nephrology, Maanshan People's Hospital, Maanshan, Anhui, China.
Han WuBlood Purification Center, Bozhou People's Hospital, Bozhou, Anhui, China.
Ji LiDepartment of Nephrology, Tongling People's Hospital, Tongling, China.
Yuwen GuoDepartment of Nephrology, Lujiang County People's Hospital, Lucheng, China.
Shanfei YangDepartment of Nephrology, Shouxian County Hospital, Suzhou, China.
Lei ChenDepartment of Nephrology, Hefei Jinnan Kidney Hospital, Hefei, China.
Jian YangDepartment of Nephrology, Funan County People's Hospital, Funan County, China.
Jiuhuai HanDepartment of Nephrology, Anqing Municipal Hospital, Anqing, China.
Shengyin MaDepartment of Nephrology, Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China.
Jing YangDepartment of Nephrology, The First People's Hospital of Hefei, Hefei, China.
Linfei YuDepartment of Nephrology, The People's Hospital of Taihu, Taihu County, China.
Runzhi ShuiBlood Purification Center, Huangshan City People's Hospital, Fuyang, China.
Xiping JinDepartment of Nephrology, Huainan Chao Yang Hospital, Huainan, China.
Hongyu WangDepartment of Nephrology, Lixin County People's Hospital, Lixin County, China.
Fan ZhangDepartment of Nephrology, Dongzhi County People's Hospital, Dongzhi County, China.
Tianhao ChenDepartment of Nephrology, Tianchang City People's Hospital, Tianchang, China.
Xinke LiDepartment of Nephrology, Xiaoxian People's Hospital, Xiaoxian County, China.
Xiaoying ZongDepartment of Nephrology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Li LiuDepartment of Nephrology, The Second People's Hospital of Hefei, Hefei, China.
Jihui FanDepartment of Nephrology, Huaibei People's Hospital, Huaibei, China.
Wei WangDepartment of Nephrology, The People's Hospital of Xuancheng City, Xuancheng, China.
Yong ZhangDepartment of Nephrology, Lujiang County Hospital of TCM, Lujiang, China.
Guangcai ShiDepartment of Nephrology, The Fifth People's Hospital of Hefei, Hefei, China.
Deguang WangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Shuman TaoDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-3582-7062
Anhui Medical University · CNFuyang City People's Hospital · CNJingning County People's Hospital · CNAnhui University · CNAnqing City Hospital · CNBozhou People's Hospital · CNHuaibei Normal University · CNHuainan Normal University · CNQujiang People's Hospital · CNThe First People's Hospital of Tianmen · CNThe People's Hospital Tongling · CNThe Second Affiliated Hospital of Bengbu Medical College · CNThird People's Hospital of Hefei · CNXian Yang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAging is a complex process of physiological dysregulation of the body system and is common in hemodialysis patients. However, limited studies have investigated the links between dialysis vintage, calcium, phosphorus, and iPTH control and aging. The purpose of the current study was to examine these associations.

methodsDuring 2020, a cross-sectional study was conducted in 3025 hemodialysis patients from 27 centers in Anhui Province, China. Biological age was calculated by a formula using chronological age and clinical indicators. The absence of the target range for serum phosphorus (0.87-1.45 mmol/L), corrected calcium (2.1-2.5 mmol/L) and iPTH (130-585 pg/mL) were identified as abnormal calcium, phosphorus, and iPTH control.

resultsA total of 1131 hemodialysis patients were included, 59.2% of whom were males (669/1131). The mean (standard deviation) of actual age and biological age were 56.07 (12.79) years and 66.94 (25.88), respectively. The median of dialysis vintage was 4.3 years. After adjusting for the confounders, linear regression models showed patients with abnormal calcium, phosphorus, and iPTH control and on hemodialysis for less than 4.3 years (

conclusionOur findings support the hypothesis that long-term hemodialysis and abnormal calcium, phosphorus, and iPTH control may accelerate aging in the hemodialysis population. Further studies are warrant to verify the significance of maintaining normal calcium-phosphorus metabolism in aging.

Indexed as

CalciumRenal DialysisAgingCross-Sectional StudiesFemaleHumansMaleMiddle AgedPhosphorusCalciumPhosphorusAgeingbiological agecalcium-phosphorus metabolismhemodialysis

Identifiers

PMID37724516
PMCPMC10512754
OpenAlexW4386846551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.